Skip to Content
Merck
  • Nitrofurantoin-induced pulmonary hemorrhage in a renal transplant recipient receiving immunosuppressive therapy: case report and review of the literature.

Nitrofurantoin-induced pulmonary hemorrhage in a renal transplant recipient receiving immunosuppressive therapy: case report and review of the literature.

The Journal of urology (1994-09-01)
M M Meyer, R J Meyer
ABSTRACT

A 33-year-old woman received a cadaveric renal transplant for focal segmental glomerulosclerosis. Nitrofurantoin urinary prophylaxis was started on postoperative day 13 but coughing and mild hemoptysis began 2 days later. Diffuse infiltrates and worsening hemoptysis led to intubation and open lung biopsy. Clinical course, culture results and pathological evaluation excluded infectious etiologies and were consistent with a drug reaction. The case is described, and the literature on the nitrofurantoin pulmonary toxicity syndromes and pathophysiology is reviewed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nitrofurantoin, 98.0-102.0% (EP, UV)
Supelco
Nitrofurantoin, VETRANAL®, analytical standard
Supelco
Nitrofurantoin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Nitrofurantoin, United States Pharmacopeia (USP) Reference Standard